Le Lézard
Classified in: Health, Business
Subjects: PDT, CSR, CXP, MAT

UK-based Eco Equity Approved for Medicinal Cannabis Licence in Antigua and Barbuda

LONDON, Nov. 20, 2019 /PRNewswire/ -- London-based medicinal cannabis company has been approved, pending ratification from the licensing Board for a medicinal cannabis Dispensary licence in Antigua and Barbuda.

Eco Equity's license will also include the manufacturing of products, supply, store, import and export for medicinal purposes and scientific use in Antigua and Barbuda.

The decision by the Cabinet of Antigua and Barbuda to approve Eco Equity to operate in Antigua and Barbuda means the company is well positioned towards achieving its aim of becoming Antigua's first and sole brand dispensary for medicinal cannabis.

The company has plans to roll the dispensary model out across the West Indies and has a long term vision to build in conjunction with the government of Antigua and Barbuda, a global cannabis resort and conference centre.

The company has stressed its commitment to creating its own Corporate Social Responsibility (CSR) program and has stated its mission to ensure jobs are given to the local community as a priority following the approval of the license application.

Jon-Paul Doran, CEO of Eco Equity, said: "It is a real honour to be considered for medicinal cannabis in Antigua and Barbuda. The progressive nature of the Prime Minister and his Government is what attracted us to the island in the first place. We are excited about the potential opportunities that will arise from this and we will be making further announcements in the coming weeks."

"Whilst we are, of course, anticipating the timely approval of the said license, we are aware that the hard work starts now and our team on the ground is ready to begin operations."

Hon. Charles Fernandez, Minister of Tourism & Investments of Antigua & Barbuda said: "The global cannabis market is expanding at an exponential rate. We have seen many business plans from many global cannabis firms and Eco Equity stood out in many areas. We commend them. We look forward to working closely with them and supporting them as they build here in Antigua and Barbuda."

Following the approval of the licence Eco Equity could become the first company to hold medicinal cannabis licenses in both Antigua and Barbuda, and Zimbabwe, as it continues to expand into the global market.

The company has already begun work on a greenhouse facility in Zimbabwe and intends to follow a similar process in Antigua and Barbuda.

About Eco Equity:

Eco Equity has acquired a licence for the cultivation of cannabis, manufacture of products, supply, store, import and export for medicinal purposes and or scientific use.

The company in association will develop, own and operate medicinal cannabis facilities with the objective to export the products derived from the facility to Europe.

With a combination of research, development, cultivating, growing and manufacturing our mission is to advance the medical extracts, related products and sector as a whole by educating communities and developing products that are safe, effective and affordable for export.


These press releases may also interest you

at 09:13
For CEOs of large health care organizations, accelerating change has become the norm for the industry. However, making progress to accommodate these changes has been harder than expected, as seen in new research from the Deloitte Center for Health...

at 09:05
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the Company recognized significant growth across the business in 2019. "In 2019 we...

at 09:05
FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that today the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The trial is led by Righshospitalet (Copenhagen,...

at 09:05
Generex Biotechnology Corporation (www.generex.com) (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased to announce that their subsidiary, Olaregen Therapeutix, Inc., is introducing an exciting new product, Excellagen Aestheticstm for the...

at 09:00
HEXO Corp ("HEXO" or the "Company") today announced it has entered into a definitive agreement with institutional investors for the purchase and sale of 11,976,048 common shares at an offering price of US$1.67 per share for gross proceeds of US$20.0...

at 09:00
Laura van 't Veer, Ph.D., co-founder of Agendia Inc. and developer of MammaPrint, the 70-gene risk of recurrence assay for breast cancer patients, will be recognized by Precision Medicine World Conference with the PMWC Luminary Award on January 21,...

News published on 20 november 2019 at 10:56 and distributed by: